MX2013000916A - Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales. - Google Patents
Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales.Info
- Publication number
- MX2013000916A MX2013000916A MX2013000916A MX2013000916A MX2013000916A MX 2013000916 A MX2013000916 A MX 2013000916A MX 2013000916 A MX2013000916 A MX 2013000916A MX 2013000916 A MX2013000916 A MX 2013000916A MX 2013000916 A MX2013000916 A MX 2013000916A
- Authority
- MX
- Mexico
- Prior art keywords
- conditions
- methods
- disease
- bodily fluids
- detecting signatures
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Physiology (AREA)
- Hospice & Palliative Care (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- General Engineering & Computer Science (AREA)
Abstract
La presente invención proporciona métodos de uso de fluidos corporales libres de células y hematocitos en el diagnóstico, pronóstico o monitoreo de enfermedades y condiciones; la invención también se refiere a métodos para utilizar fluidos corporales libres de células y hematocitos para identificar marcadores de enfermedades o condiciones.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36700610P | 2010-07-23 | 2010-07-23 | |
PCT/US2011/044969 WO2012012693A2 (en) | 2010-07-23 | 2011-07-22 | Methods for detecting signatures of disease or conditions in bodily fluids |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2013000916A true MX2013000916A (es) | 2013-07-05 |
MX361944B MX361944B (es) | 2018-12-19 |
Family
ID=45497477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013000916A MX361944B (es) | 2010-07-23 | 2011-07-22 | Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales. |
Country Status (12)
Country | Link |
---|---|
US (5) | US20120053073A1 (es) |
EP (2) | EP2596132A4 (es) |
JP (5) | JP2013538565A (es) |
KR (1) | KR20130041961A (es) |
CN (2) | CN103119179A (es) |
AU (2) | AU2011280996B2 (es) |
BR (1) | BR112013001754A2 (es) |
CA (1) | CA2806291C (es) |
EA (1) | EA201390150A1 (es) |
MX (1) | MX361944B (es) |
SG (2) | SG187159A1 (es) |
WO (1) | WO2012012693A2 (es) |
Families Citing this family (105)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0906858B8 (pt) | 2008-01-18 | 2021-07-27 | Harvard College | métodos in vitro para detectar a presença de uma célula de câncer em um indivíduo e para identificar uma assinatura específica de tumor em um indivíduo tendo câncer. |
EP2596116A4 (en) | 2010-07-23 | 2014-03-19 | Harvard College | METHODS FOR DETECTION OF AUTOIMMUNE OR IMMUNE-RELATED DISEASES / PATHOLOGIES |
AU2011280936A1 (en) | 2010-07-23 | 2013-02-28 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
KR101212714B1 (ko) * | 2011-01-26 | 2013-01-22 | 계명대학교 산학협력단 | 계층적 퍼지 추론에 기반한 임상진단 지원방법 및 그 시스템 |
AU2013211850B8 (en) | 2012-01-27 | 2017-06-29 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for profiling and quantitating cell-free RNA |
US9220733B2 (en) | 2012-03-19 | 2015-12-29 | The Regents Of The University Of California | Solubilization of antigen components for removal from tissues |
WO2013162458A1 (en) * | 2012-04-24 | 2013-10-31 | Wahren Herlenius Marie | Ro52 AS A PREDICTIVE MARKER FOR IMMUNE DERIVED TUMOR OUTCOME |
WO2013173642A1 (en) * | 2012-05-18 | 2013-11-21 | Sanford-Burnham Medical Research Institute | High-throughput lipidomics |
CN104603289A (zh) * | 2012-06-15 | 2015-05-06 | 哈里·斯泰利 | 检测疾病或病状的方法 |
BR112014031414A2 (pt) * | 2012-06-15 | 2017-06-27 | Stylli Harry | métodos de detectar doenças ou condições utilizando células doentes circulantes |
US11913065B2 (en) | 2012-09-04 | 2024-02-27 | Guardent Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
EP2893040B1 (en) | 2012-09-04 | 2019-01-02 | Guardant Health, Inc. | Methods to detect rare mutations and copy number variation |
US10876152B2 (en) | 2012-09-04 | 2020-12-29 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US20160040229A1 (en) | 2013-08-16 | 2016-02-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
EP3536807B1 (en) * | 2012-09-20 | 2023-11-29 | The Chinese University of Hong Kong | Non-invasive determination of methylome of tumor from plasma |
US10706957B2 (en) | 2012-09-20 | 2020-07-07 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of tumor from plasma |
US9732390B2 (en) | 2012-09-20 | 2017-08-15 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of fetus or tumor from plasma |
US20150252428A1 (en) * | 2012-10-03 | 2015-09-10 | Exosome Diagnostics, Inc. | Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions |
CN102912029A (zh) * | 2012-11-06 | 2013-02-06 | 俞杨 | 一种检测人结核杆菌相关易感基因cish +1320位点的单核苷酸多态性的方法 |
GB201220573D0 (en) | 2012-11-15 | 2013-01-02 | Univ Central Lancashire | Methods of diagnosing proliferative disorders |
GB201302837D0 (en) * | 2013-02-19 | 2013-04-03 | Univ Singapore | Therapeutic Agents |
EP2965086A4 (en) | 2013-03-09 | 2017-02-08 | Harry Stylli | Methods of detecting prostate cancer |
US10494675B2 (en) | 2013-03-09 | 2019-12-03 | Cell Mdx, Llc | Methods of detecting cancer |
CN118028467A (zh) * | 2013-03-14 | 2024-05-14 | 梅奥医学教育和研究基金会 | 检测赘生物 |
US10119978B2 (en) * | 2013-03-15 | 2018-11-06 | Wallac Oy | System and method for determining risk of diabetes based on biochemical marker analysis |
WO2014170497A2 (en) * | 2013-04-19 | 2014-10-23 | Epiontis Gmbh | Method for identifying the quantitative cellular composition in a biological sample |
CN103293321B (zh) * | 2013-05-27 | 2015-05-13 | 北京大学 | 一种检测dna损伤诱导的早期核仁应激的试剂盒及其应用 |
CN103555818A (zh) * | 2013-07-16 | 2014-02-05 | 中国人民解放军海军医学研究所 | B细胞转位基因2作为低剂量电离辐射生物剂量计的应用 |
EP3024949B1 (en) * | 2013-07-24 | 2019-03-06 | The Chinese University Of Hong Kong | B3gnt5 for use as a biomarker for premature birth |
CN104374853A (zh) * | 2013-08-14 | 2015-02-25 | 柯跃斌 | 高效液相色谱质谱联用检测dna氧化与dna甲基化的方法 |
US10745754B2 (en) | 2013-11-27 | 2020-08-18 | Bioscreening & Diagnostics Llc | Method for predicting congenital heart defect |
WO2015095359A1 (en) * | 2013-12-17 | 2015-06-25 | Harry Stylli | Methods of detecting diseases or conditions |
JP6571665B2 (ja) | 2013-12-28 | 2019-09-04 | ガーダント ヘルス, インコーポレイテッド | 遺伝的バリアントを検出するための方法およびシステム |
JP6484636B2 (ja) | 2014-01-16 | 2019-03-13 | イラミーナ インコーポレーテッド | 固相担体におけるアンプリコン調製および配列決定 |
CN106062215B (zh) * | 2014-02-28 | 2020-09-22 | 国立研究开发法人国立癌研究中心 | 肾细胞癌的预后判定方法 |
ES2812753T3 (es) | 2014-03-31 | 2021-03-18 | Mayo Found Medical Education & Res | Detección de neoplasma colorectal |
MA39951A (fr) * | 2014-05-09 | 2017-03-15 | Lifecodexx Ag | Détection de l'adn provenant d'un type spécifique de cellule et méthodes associées |
EP2942400A1 (en) | 2014-05-09 | 2015-11-11 | Lifecodexx AG | Multiplex detection of DNA that originates from a specific cell-type |
WO2015176066A2 (en) * | 2014-05-16 | 2015-11-19 | Intermune, Inc. | Lpa-associated protein and rna expression |
CN104101715A (zh) * | 2014-07-15 | 2014-10-15 | 重庆医科大学附属儿童医院 | 检测dock8蛋白的试剂盒及非诊断目的检测dock8蛋白的方法 |
WO2016040843A1 (en) * | 2014-09-11 | 2016-03-17 | Harry Stylli | Methods of detecting prostate cancer |
CN104357559A (zh) * | 2014-10-27 | 2015-02-18 | 同济大学 | 日本血吸虫雌虫发育调控关键核糖体蛋白的鉴定方法 |
CN104280478B (zh) * | 2014-11-03 | 2016-03-30 | 天津中医药大学 | 内源性小分子物质在快速检测肾毒性方面的应用 |
JP2017538404A (ja) | 2014-11-14 | 2017-12-28 | リキッド ジェノミクス,インコーポレイティド | 癌を診断及び/又は観察するための循環無細胞rnaの使用 |
WO2016095093A1 (zh) * | 2014-12-15 | 2016-06-23 | 天津华大基因科技有限公司 | 肿瘤筛查方法、目标区域变异检测方法和装置 |
US10030272B2 (en) | 2015-02-27 | 2018-07-24 | Mayo Foundation For Medical Education And Research | Detecting gastrointestinal neoplasms |
EP3316159A4 (en) | 2015-06-25 | 2019-08-14 | Advanced Telecommunications Research Institute International | PREDICTIVE EQUIPMENT BASED ON A SYSTEM ASSOCIATED WITH SEVERAL INSTITUTIONS AND PREDICTION PROGRAM |
WO2017040627A1 (en) | 2015-08-31 | 2017-03-09 | Mayo Foundation For Medical Education And Research | Detecting gastric neoplasm |
CA2998680C (en) * | 2015-09-17 | 2024-01-02 | Consejo Superior De Investigaciones Cientificas | Method for detecting circulating cells in superficial body fluids |
US20170097355A1 (en) * | 2015-10-06 | 2017-04-06 | University Of Washington | Biomarkers and methods to distinguish ovarian cancer from benign tumors |
EP3168309B8 (en) | 2015-11-10 | 2020-06-03 | Eurofins LifeCodexx GmbH | Detection of foetal chromosomal aneuploidies using dna regions that are differentially methylated between the foetus and the pregnant female |
WO2017097852A2 (en) * | 2015-12-07 | 2017-06-15 | Zora Biosciences Oy | Use of ceramides and lpls in diagnosing cvd |
WO2017106768A1 (en) | 2015-12-17 | 2017-06-22 | Guardant Health, Inc. | Methods to determine tumor gene copy number by analysis of cell-free dna |
CN105506083B (zh) * | 2015-12-24 | 2018-10-19 | 孙梅芬 | Capg在制备诊断帕金森症产品中的用途 |
CN205301177U (zh) * | 2015-12-31 | 2016-06-08 | 深圳市贝沃德克生物技术研究院有限公司 | 家用肺炎支原体感染检测系统 |
WO2017122816A1 (ja) | 2016-01-15 | 2017-07-20 | 公益財団法人がん研究会 | 新規融合体及びその検出法 |
WO2017136603A1 (en) | 2016-02-02 | 2017-08-10 | Guardant Health, Inc. | Cancer evolution detection and diagnostic |
CN105842037B (zh) * | 2016-03-21 | 2018-07-31 | 山东农业大学 | 一种同时显示肥大细胞与嗜酸性细胞的染色方法 |
CN109196119A (zh) | 2016-03-29 | 2019-01-11 | 株式会社国际电气通信基础技术研究所 | 用以预防或治疗选自由肾功能减退、慢性肾病和肾衰竭组成的组中的至少一种疾病的活性组分的候选物质的筛选方法 |
EP3466446B1 (en) | 2016-03-29 | 2023-12-27 | Karydo Therapeutix, Inc. | Pharmaceutical composition or food composition, and method for assessing effect of active ingredient in vivo |
US10370726B2 (en) | 2016-04-14 | 2019-08-06 | Mayo Foundation For Medical Education And Research | Detecting colorectal neoplasia |
CN105784873B (zh) * | 2016-05-06 | 2017-10-13 | 常熟市医学检验所 | 基于代谢组学的高尿酸性肾损伤早期诊断标志物及其应用 |
MX2018015184A (es) * | 2016-06-07 | 2019-04-24 | Univ Leland Stanford Junior | Métodos para el diagnóstico de infecciones bacterianas y virales. |
CN107144620A (zh) * | 2017-03-31 | 2017-09-08 | 兰州百源基因技术有限公司 | 糖尿病肾病检测标志物 |
WO2018183747A1 (en) * | 2017-03-31 | 2018-10-04 | The Regents Of The University Of California | Shotgun proteomic antigen identification |
CN107328746B (zh) * | 2017-06-14 | 2020-01-31 | 宁波大学 | 基于类核酸配位聚合物的多功能荧光生物传感器的制备及应用 |
US20200141948A1 (en) * | 2017-06-21 | 2020-05-07 | Korea Research Institute Of Bioscience And Biotechnology | Method and kit for diagnosis of muscle weakness-related diseases using blood biomarker |
WO2019018545A1 (en) | 2017-07-18 | 2019-01-24 | The Research Foundation For The State University Of New York | BIOMARKERS OF INTRACRANIAL ANEVISM |
AU2018312117B2 (en) * | 2017-08-04 | 2022-05-12 | Billiontoone, Inc. | Sequencing output determination and analysis with target-associated molecules in quantification associated with biological targets |
EP3665301B1 (en) * | 2017-08-09 | 2023-10-04 | PamGene B.V. | Method for predicting the response of non-small-cell lung carcinoma patients to a medicament |
EP3713552A1 (en) | 2017-11-23 | 2020-09-30 | Biosearch S.A. | Method for increasing embryo implantation rate in a female subject suffering polycystic ovary syndrome |
CN109658980B (zh) * | 2018-03-20 | 2023-05-09 | 上海交通大学医学院附属瑞金医院 | 一种粪便基因标志物的筛选及应用 |
KR102072504B1 (ko) * | 2018-05-23 | 2020-02-03 | 중앙대학교 산학협력단 | Dock8 유전자 단일염기다형성을 이용한 아토피 피부염 진단용 조성물과 검출 방법 |
WO2019232512A1 (en) * | 2018-06-01 | 2019-12-05 | Musc Foundatiion For Research Development | Glycan analysis of proteins and cells |
CN108841928B (zh) * | 2018-06-11 | 2021-11-23 | 河北医科大学 | 一种人类线粒体基因组甲基化检测试剂盒及其应用 |
BR112021003477A2 (pt) * | 2018-06-14 | 2021-05-18 | Metabolomycs, Inc. | assinaturas metabolômicas para prever, diagnosticar e prognosticar várias doenças incluindo câncer |
CN108796067B (zh) * | 2018-07-03 | 2019-10-25 | 北京泱深生物信息技术有限公司 | 血液中maea基因的诊断新功能 |
CN109266734A (zh) * | 2018-09-25 | 2019-01-25 | 深圳市人民医院 | 自身免疫性疾病诊断试剂盒和应用 |
CN109295230A (zh) * | 2018-10-24 | 2019-02-01 | 福建翊善生物科技有限公司 | 一种基于ctDNA的多基因联合突变检测评估肿瘤动态变化的方法 |
EP3924972A4 (en) | 2019-02-14 | 2023-03-29 | Mirvie, Inc. | METHOD AND SYSTEMS FOR DETERMINING A PREGNANCY-ASSOCIATED CONDITION IN A SUBJECT |
CN113853443A (zh) * | 2019-03-08 | 2021-12-28 | 株式会社Neogentc | 用于预测淋巴细胞的肿瘤反应性的标志物及其用途 |
CN109821029B (zh) * | 2019-04-08 | 2020-12-15 | 浙江大学 | Zdhhc21基因在制备白血病诱导分化治疗药物中的应用 |
KR102169901B1 (ko) * | 2019-05-17 | 2020-10-26 | 연세대학교 산학협력단 | Dna 메틸화를 이용한 면역 항암 요법의 치료 반응에 관한 정보 제공 방법 및 이를 이용한 키트 |
WO2020243589A1 (en) * | 2019-05-29 | 2020-12-03 | Washington University | Methods of detecting clostridium difficile infections |
WO2021041931A1 (en) * | 2019-08-28 | 2021-03-04 | The Regents Of The University Of California | Methods of producing dna methylation profiles |
CN110514847B (zh) * | 2019-09-24 | 2022-06-10 | 北京市心肺血管疾病研究所 | 血清LysoPA在小儿扩张型心肌病预后中的应用 |
CN112697889B (zh) * | 2019-10-22 | 2022-03-08 | 中国科学院大连化学物理研究所 | 一种血清代谢标志物的用途及检测试剂盒 |
CN111189683A (zh) * | 2020-01-06 | 2020-05-22 | 中国科学院地质与地球物理研究所 | 一种离子探针液体样品靶的制备方法 |
CN111341448B (zh) * | 2020-03-03 | 2023-12-19 | 西安交通大学 | 一种基于孟德尔随机化预测复杂疾病及表型相关代谢物的方法 |
CN111041089B (zh) * | 2020-03-13 | 2020-06-19 | 广州微远基因科技有限公司 | Covid-19感染的宿主标志物的应用 |
WO2021201111A1 (ja) * | 2020-04-01 | 2021-10-07 | あすか製薬株式会社 | 破壊性甲状腺炎を他の病態から鑑別する方法 |
CN111334572B (zh) * | 2020-04-26 | 2020-10-27 | 江苏大学附属医院 | Ctsz基因甲基化的新用途 |
CN112305220B (zh) * | 2020-06-03 | 2021-07-23 | 四川大学华西第二医院 | 组织蛋白酶z在子痫前期的早期预警、诊断中的应用和产品 |
CN111679018B (zh) * | 2020-08-14 | 2020-11-20 | 宝枫生物科技(北京)有限公司 | 用于诊断认知障碍的生物标记物及其应用 |
CN112305118B (zh) * | 2020-10-30 | 2022-03-22 | 河北医科大学第二医院 | L-辛酰基肉碱作为疾病诊断的生物标志物 |
CN112501175A (zh) * | 2020-12-14 | 2021-03-16 | 南通大学 | 一种银屑病抑制基因及其应用 |
US11152103B1 (en) | 2020-12-29 | 2021-10-19 | Kpn Innovations, Llc. | Systems and methods for generating an alimentary plan for managing musculoskeletal system disorders |
CN113295874B (zh) * | 2021-05-25 | 2022-03-04 | 广东源心再生医学有限公司 | 一种用于瓣膜性心脏病辅助诊断的新型标志物、辅助诊断的产品 |
CN113267394A (zh) * | 2021-06-10 | 2021-08-17 | 谱天(天津)生物科技有限公司 | 用于蛋白质组质控的ffpe参考品、其制备方法及应用 |
CN113252910B (zh) * | 2021-06-29 | 2022-05-17 | 中国人民解放军军事科学院军事医学研究院 | Timp3在焦虑抑郁症诊断中的应用 |
WO2023279213A1 (en) * | 2021-07-09 | 2023-01-12 | Uti Limited Partnership | Metabolomic profiles for prediction of functional neurological outcome or death following severe traumatic brain injury |
WO2023044118A1 (en) * | 2021-09-20 | 2023-03-23 | Droplet Biosciences, Inc. | Methods for disease assessment using drain fluid |
WO2023250229A1 (en) * | 2022-06-23 | 2023-12-28 | Oklahoma Medical Research Foundation | Autoantibody biomarkers of ro/ss-a antibody negative sjogren's syndrome/sjogren's disease |
CN115575646B (zh) * | 2022-11-21 | 2023-04-28 | 四川大学华西医院 | 一种代谢标志物组在制备预测癫痫发作的试剂盒中的用途 |
CN118518454B (zh) * | 2024-07-23 | 2024-09-13 | 天津医科大学第二医院 | 一种适用于质谱检测的样本预处理装置 |
Family Cites Families (229)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4868103A (en) | 1986-02-19 | 1989-09-19 | Enzo Biochem, Inc. | Analyte detection by means of energy transfer |
US4843155A (en) | 1987-11-19 | 1989-06-27 | Piotr Chomczynski | Product and process for isolating RNA |
US5459039A (en) | 1989-05-12 | 1995-10-17 | Duke University | Methods for mapping genetic mutations |
CA2087413A1 (en) | 1992-01-17 | 1993-07-18 | Joseph R. Lakowicz | Fluorescent energy transfer immunoassay |
JPH08509857A (ja) | 1993-01-07 | 1996-10-22 | シーケノム・インコーポレーテッド | マススペクトロメトリーによるdna配列決定法 |
WO1994021686A1 (en) | 1993-03-19 | 1994-09-29 | Northern Sydney Area Health Service | Papp-a, its immunodetection and uses |
US5594637A (en) | 1993-05-26 | 1997-01-14 | Base Ten Systems, Inc. | System and method for assessing medical risk |
US5498531A (en) | 1993-09-10 | 1996-03-12 | President And Fellows Of Harvard College | Intron-mediated recombinant techniques and reagents |
US5514598A (en) | 1993-11-30 | 1996-05-07 | Doody; Michael | Prenatal detection of meconium |
US6025395A (en) | 1994-04-15 | 2000-02-15 | Duke University | Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders |
US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
US6031088A (en) | 1996-05-23 | 2000-02-29 | Albert Einstein College Of Medicine Of Yeshiva University | Polycystic kidney disease PKD2 gene and uses thereof |
US20010051341A1 (en) | 1997-03-04 | 2001-12-13 | Isis Innovation Limited | Non-invasive prenatal diagnosis |
GB9704444D0 (en) | 1997-03-04 | 1997-04-23 | Isis Innovation | Non-invasive prenatal diagnosis |
US20020119118A1 (en) | 1997-11-03 | 2002-08-29 | Genentech, Inc. | Novel polypeptides and nucleic acids encoding bolekine |
WO2000040749A2 (en) | 1999-01-06 | 2000-07-13 | Genenews Inc. | Method for the detection of gene transcripts in blood and uses thereof |
AU2005200170A1 (en) * | 1999-03-05 | 2005-02-10 | University Of Iowa Research Foundation | Diagnostics and therapeutics for drusen associated ocular disorders |
US6762032B1 (en) | 1999-08-23 | 2004-07-13 | Biocrystal, Ltd. | Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response |
AU2001275346A1 (en) | 2000-06-05 | 2001-12-17 | General Hospital Corporation | Compositions, kits, and methods for identification and modulation of type i diabetes |
DE50113102D1 (de) | 2000-06-27 | 2007-11-22 | Von Recklinghausen Ges E V | Verfahren zur Ermittlung von Daten zur präsymptomatischen oder pränatalen Diagnose von Typ 1 Neurofibromatose |
US6664056B2 (en) | 2000-10-17 | 2003-12-16 | The Chinese University Of Hong Kong | Non-invasive prenatal monitoring |
FR2816411B1 (fr) | 2000-11-03 | 2003-07-04 | Inst Nat Sante Rech Med | Moyens de detection de la transformation pathologique de la proteine app et leurs applications |
US20030064380A1 (en) * | 2001-01-29 | 2003-04-03 | The Center For Blood Research, Inc. | Anergy-regulated molecules |
US6753137B2 (en) | 2001-01-31 | 2004-06-22 | The Chinese University Of Hong Kong | Circulating epstein-barr virus DNA in the serum of patients with gastric carcinoma |
GB0104690D0 (en) | 2001-02-26 | 2001-04-11 | Cytogenetic Dna Services Ltd | Diagnostic test |
FR2824144B1 (fr) | 2001-04-30 | 2004-09-17 | Metagenex S A R L | Methode de diagnostic prenatal sur cellule foetale isolee du sang maternel |
DE10291986D2 (de) | 2001-05-09 | 2004-04-15 | Biovision Ag | Verfahren zum Nachweis einer progredienten, chronisch-demenziellen Erkrankung, zugehörige Peptide und Nachweisreagenzien |
WO2003019193A1 (en) | 2001-08-30 | 2003-03-06 | Ciphergen Biosystems, Inc. | Method of diagnosing nephrotic syndrome |
US6927028B2 (en) | 2001-08-31 | 2005-08-09 | Chinese University Of Hong Kong | Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA |
US7744876B2 (en) | 2002-04-09 | 2010-06-29 | The Curators Of The University Of Missouri | Methods and compositions for treatment, prevention, suppression, and/or delaying the onset of type 1 diabetes |
US7009038B2 (en) | 2002-05-02 | 2006-03-07 | Univ. Of Medicine & Dentistry Of N.J. | pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof |
HUE039881T2 (hu) | 2002-05-09 | 2019-02-28 | Brigham & Womens Hospital Inc | 1L1RL-1, mint egy kardiovaszkuláris betegség-marker |
US20040009518A1 (en) | 2002-05-14 | 2004-01-15 | The Chinese University Of Hong Kong | Methods for evaluating a disease condition by nucleic acid detection and fractionation |
US7157235B2 (en) | 2002-06-17 | 2007-01-02 | St. Vincent's Hospital Sydney Limited | Methods of diagnosis, prognosis and treatment of cardiovascular disease |
WO2004005921A1 (en) | 2002-07-05 | 2004-01-15 | Evotec Neurosciences Gmbh | Diagnostic and therapeutic use of tb2 gene and protein for neurodegenerative diseases |
FR2844279A1 (fr) | 2002-09-06 | 2004-03-12 | Inst Nat Sante Rech Med | Moyens de detection des processus neurodegeneratifs et leurs applications |
WO2004024098A2 (en) | 2002-09-16 | 2004-03-25 | Abgenix, Inc. | Method for the treatment of nephritis using anti-pdgf-dd antibodies |
WO2004030522A2 (en) | 2002-10-02 | 2004-04-15 | Dmi Biosciences, Inc. | Diagnosis and monitoring of diseases |
US20040086864A1 (en) | 2002-10-22 | 2004-05-06 | The Chinese University Of Hong Kong | Novel classification methods for pleural effusions |
GB0225360D0 (en) | 2002-10-31 | 2002-12-11 | Univ London | Genetic markers |
AU2002952993A0 (en) | 2002-11-29 | 2002-12-12 | The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland | Therapeutic and diagnostic agents |
CN100379882C (zh) | 2003-01-17 | 2008-04-09 | 香港中文大学 | 作为妊娠相关病症的诊断标志物的循环mRNA |
WO2004070388A1 (en) | 2003-02-04 | 2004-08-19 | Evotec Neurosciences Gmbh | Diagnostic and therapeutic use of scn2b protein for neurodegenerative diseases |
US20080107600A1 (en) | 2003-02-13 | 2008-05-08 | Taiichi Katayama | Gene Marker And Composition For Diagnosis And Treatment Of Neurological Disorders And Diseases And Use Of The Same |
WO2004076639A2 (en) | 2003-02-26 | 2004-09-10 | Wyeth | Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus |
CA2529759A1 (en) | 2003-06-20 | 2005-10-13 | University Of Florida | Biomarkers for differentiating between type 2 and type 2 diabetes |
DE10333406A1 (de) | 2003-07-15 | 2005-02-10 | Protagen Ag | T-regulatorische-Zellen enthaltend Galectine zur Therapie und Diagnose von Erkrankungen |
WO2005012907A1 (en) | 2003-08-01 | 2005-02-10 | Renovar, Inc. | Systems and methods for characterizing kidney diseases |
WO2005023091A2 (en) | 2003-09-05 | 2005-03-17 | The Trustees Of Boston University | Method for non-invasive prenatal diagnosis |
US7445886B2 (en) | 2003-09-10 | 2008-11-04 | Board Of Regents, The University Of Texas System | Macrophage migration inhibitory factor as a marker for cardiovascular risk |
CA2539535A1 (en) | 2003-10-03 | 2005-04-14 | Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services | Use of cripto-1 as a biomarker for neurodegenerative disease and method of inhibiting progression thereof |
CA2541706C (en) | 2003-10-08 | 2014-02-18 | The Trustees Of Boston University | Methods for prenatal diagnosis of chromosomal abnormalities |
DE60328193D1 (de) | 2003-10-16 | 2009-08-13 | Sequenom Inc | Nicht invasiver Nachweis fötaler genetischer Merkmale |
EP1685410A1 (en) | 2003-11-19 | 2006-08-02 | EVOTEC Neurosciences GmbH | Diagnostic and therapeutic use of the human sgpl1 gene and protein for neurodegenerative diseases |
US20060094064A1 (en) | 2003-11-19 | 2006-05-04 | Sandip Ray | Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids |
CA2546461A1 (en) | 2003-11-19 | 2005-06-09 | Satoris, Inc. | Methods for diagnosis, stratification, and monitoring of alzheimer`s disease |
WO2005072340A2 (en) | 2004-01-27 | 2005-08-11 | Compugen Ltd. | Novel polynucleotides encoding polypeptides and methods using same |
EP1711633A1 (en) | 2004-02-04 | 2006-10-18 | EVOTEC Neurosciences GmbH | Diagnostic and therapeutic use of the kcne4 gene and protein for alzheimer disease |
US20050266432A1 (en) | 2004-02-26 | 2005-12-01 | Illumina, Inc. | Haplotype markers for diagnosing susceptibility to immunological conditions |
EP1733231B1 (en) | 2004-04-05 | 2011-05-04 | Université Bordeaux 2 | Peptides and peptidomimetics binding to cd23 |
US20080051334A1 (en) | 2004-04-16 | 2008-02-28 | Evotec Neurosciences Gmbh | Diagnostic and Therapeutic Use of Kcnc1 for Neurodegenerative Diseases |
EP1740957B1 (en) | 2004-04-20 | 2014-03-12 | SphingoTec GmbH | Use of precursors of tachykinins and/or their fragments in medical diagnostic |
US20090041862A1 (en) | 2004-05-07 | 2009-02-12 | Peter Robert Schofield | Detecting disease association with aberrant glycogen synthase kinase 3beta expression |
US20080038730A1 (en) | 2004-05-10 | 2008-02-14 | Heinz Von Der Kammer | Diagnostic and Therapeutic Use of Kcnj6 for Alzheimer's Disease |
WO2005114222A1 (en) | 2004-05-13 | 2005-12-01 | Sphingo Tec Gmbh | Use of precursors of enkephalins and/or their fragments in medical diagnostics |
WO2005111626A2 (en) | 2004-05-19 | 2005-11-24 | Københavns Universitet | Adam12, a novel marker for abnormal cell function |
US7709194B2 (en) | 2004-06-04 | 2010-05-04 | The Chinese University Of Hong Kong | Marker for prenatal diagnosis and monitoring |
EP1797425A2 (en) | 2004-07-19 | 2007-06-20 | University of Rochester | Biomarkers of neurodegenerative disease |
EP1778874B1 (en) | 2004-07-30 | 2011-11-23 | Adeza Biomedical Corporation | Oncofetal fibronectin as a marker for cervical cancer |
WO2006020899A2 (en) | 2004-08-13 | 2006-02-23 | Metrigenix Corporation | Markers for autoimmune disease detection |
US20070087376A1 (en) | 2004-08-30 | 2007-04-19 | Potashkin Judith A | Splice variants of pre-mRNA transcripts as biomarkers in idiopathic neurodegenerative diseases |
WO2006032126A1 (en) | 2004-09-24 | 2006-03-30 | Syn X Pharma, Inc. | Diagnosis and treatment of early pre-type-1 diabetes utilizing neuronal proteins |
US7595159B2 (en) | 2004-11-03 | 2009-09-29 | The Brigham And Women's Hospital, Inc. | Prediction of Parkinson's disease using gene expression levels of peripheral blood samples |
WO2006048778A1 (en) | 2004-11-08 | 2006-05-11 | King's College London | Markers of predisposition to addictive states |
US20060115855A1 (en) | 2004-12-01 | 2006-06-01 | Power3 Medical Products, Inc. | FK506-binding protein 7 related protein as a biomarker for neurodegenerative disease |
US20060115854A1 (en) | 2004-12-01 | 2006-06-01 | Power3 Medical Products, Inc. | Acetyl-LDL receptor related proteins and peptides as a biomarker for neurodegenerative disease |
GB0426859D0 (en) | 2004-12-07 | 2005-01-12 | Proteome Sciences Plc | Diagnosis of neurodegenerative disorders |
CA2590781A1 (en) | 2004-12-07 | 2006-06-15 | Electrophoretics Limited | Diagnosis of neurodegenerative diseases |
EP1838735A2 (en) | 2004-12-31 | 2007-10-03 | Genentech, Inc. | Polypeptides that bind br3 and uses thereof |
FR2880897B1 (fr) | 2005-01-18 | 2010-12-17 | Inst Nat Sante Rech Med | Methode de detection, non invasive, prenatale, in vitro de l'etat sain normal, de l'etat de porteur sain ou de l'etat de porteur malade de la mucoviscidose |
US7432107B2 (en) | 2005-01-24 | 2008-10-07 | Roche Diagnostics Operations, Inc. | Cardiac hormones for assessing cardiovascular risk |
US7572592B2 (en) | 2005-01-31 | 2009-08-11 | Glycominds Ltd | Method for diagnosing multiple sclerosis |
US20070141625A1 (en) | 2005-02-03 | 2007-06-21 | Santos Jose H | Method for assessing risk of and predisposition to development of a pathology related to the presence of anti-epcr autoantibodies |
EP2612928A3 (en) | 2005-03-18 | 2013-09-11 | The Chinese University Of Hong Kong | Markers for prenatal diagnosis and monitoring |
JP5219516B2 (ja) | 2005-03-18 | 2013-06-26 | ザ チャイニーズ ユニバーシティー オブ ホンコン | 染色体異数性の検出方法 |
WO2006102498A2 (en) | 2005-03-24 | 2006-09-28 | Beth Israel Deaconess Medical Center | Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy |
PT2146209E (pt) | 2005-04-06 | 2011-12-30 | Univ Antwerp | Marcadores neurodegenerativos para a doença de alzheimer |
NZ562436A (en) | 2005-04-18 | 2010-01-29 | Provost Fellows & Scholars Of | Toll-like receptor 14 (TLR14) and use thereof |
WO2006114661A1 (en) | 2005-04-26 | 2006-11-02 | Dwek Raymond A | High throughput glycan analysis for diagnosing and monitoring rheumatoid arthritis and other autoimmune diseases |
AU2006247134B2 (en) | 2005-05-18 | 2012-05-10 | Novartis Ag | Methods for diagnosis and treatment of diseases having an autoimmune and/or inflammatory component |
GB0512401D0 (en) | 2005-06-17 | 2005-07-27 | Randox Lab Ltd | Method |
GB2428240A (en) | 2005-07-14 | 2007-01-24 | Univ Gen Ve | Diagnostic method for brain damage-related disorders |
US20070148661A1 (en) | 2005-07-19 | 2007-06-28 | Duke University | LSAMP Gene Associated With Cardiovascular Disease |
US20070218469A1 (en) | 2005-10-03 | 2007-09-20 | Ruth Navon | Novel mutations in hexosaminidase A |
IL172297A (en) | 2005-10-03 | 2016-03-31 | Compugen Ltd | Soluble vegfr-1 variants for the diagnosis of preeclampsia |
AU2006302031A1 (en) | 2005-10-11 | 2007-04-19 | Tethys Bioscience, Inc. | Diabetes-associated markers and methods of use thereof |
US8652467B2 (en) | 2005-10-14 | 2014-02-18 | The Regents Of The University Of Michigan | Dek protein compositions and methods of using the same |
TW200726845A (en) | 2006-01-02 | 2007-07-16 | Nat Defense Medical Ct | Biomarker molecular of renal illness and detecting method for the same |
EP1808694A1 (en) | 2006-01-17 | 2007-07-18 | Universitätsklinikum Freiburg | Method for diagnosing polycystic kidney disease |
FR2896588B1 (fr) | 2006-01-20 | 2016-08-19 | Univ D'angers | Methode de diagnostic in vitro de reponse immunitaire autoimmune par detection d'anticorps diriges contre l'antigene pentraxine 3. |
WO2007090126A2 (en) | 2006-01-30 | 2007-08-09 | Invitrogen Corporation | Compositions and methods for detecting and quantifying toxic substances in disease states |
US7459280B2 (en) | 2006-02-27 | 2008-12-02 | Picobella, Llc | Methods for diagnosing and treating kidney cancer |
WO2007098585A1 (en) | 2006-02-28 | 2007-09-07 | Phenomenome Discoveries Inc. | Methods for the diagnosis of dementia and other neurological disorders |
US7488584B2 (en) | 2006-03-24 | 2009-02-10 | Picobella | Methods for diagnosing and treating kidney and colorectal cancer |
US20070224638A1 (en) | 2006-03-27 | 2007-09-27 | Institut Pasteur | Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections |
GB0606776D0 (en) | 2006-04-03 | 2006-05-10 | Novartis Pharma Ag | Predictive biomarkers for chronic allograft nephropathy |
EP1847615A1 (en) | 2006-04-18 | 2007-10-24 | Genoscreen | Expression and polymorphism of the ornithine transcarbamylase (OTC) gene as markers for diagnosing Alzheimer's disease |
US7662578B2 (en) | 2006-04-21 | 2010-02-16 | Children's Hospital Medical Center | Method and kit for the early detection of impaired renal status |
EP2021799B1 (en) | 2006-04-27 | 2011-07-20 | Critical Care Diagnostics, Inc. | Interleukin-33 (il-33) for the diagnosis and prognosis of cardiovascular disease |
JP5377289B2 (ja) | 2006-05-01 | 2013-12-25 | クリティカル ケア ダイアグノスティクス インコーポレイテッド | 心血管疾患の診断方法 |
US7754428B2 (en) | 2006-05-03 | 2010-07-13 | The Chinese University Of Hong Kong | Fetal methylation markers |
US7901884B2 (en) | 2006-05-03 | 2011-03-08 | The Chinese University Of Hong Kong | Markers for prenatal diagnosis and monitoring |
WO2007131345A1 (en) | 2006-05-12 | 2007-11-22 | The Hospital For Sick Children | Genetic risk factor in sod1 and sfrs15 in renal disease, diabetic cataract, cardiovascular disease and longevity |
US8257933B2 (en) | 2006-05-12 | 2012-09-04 | Keio University | Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease |
ES2497641T3 (es) | 2006-05-17 | 2014-09-23 | The Ludwig Institute For Cancer Research | Dirección a la regulación de VEGF-B de transportadores de ácidos grasos para modular enfermedades humanas |
WO2007139895A2 (en) | 2006-05-24 | 2007-12-06 | Cellumen, Inc. | Method for modeling a disease |
US20080038269A1 (en) | 2006-05-25 | 2008-02-14 | Mount Sinai Hospital | Methods for detecting and treating kidney disease |
DE102006027818A1 (de) | 2006-06-16 | 2007-12-20 | B.R.A.H.M.S. Aktiengesellschaft | In vitro Multiparameter-Bestimmungsverfahren zur Diagnose und Frühdiagnose von neurodegenerativen Erkrankungen |
WO2008084331A2 (en) | 2006-06-21 | 2008-07-17 | Hopitaux Universitaires De Geneve | Biomarkers for renal disorders |
WO2008003826A1 (en) | 2006-07-07 | 2008-01-10 | Oy Jurilab Ltd | Novel genes and markers in essential arterial hypertension |
KR100856375B1 (ko) | 2006-07-18 | 2008-09-04 | 김현기 | 퇴행성 신경질환 진단용 마커 |
US7851172B2 (en) | 2006-07-25 | 2010-12-14 | University Of Kentucky Research Foundation | Biomarkers of mild cognitive impairment and alzheimer's disease |
US20080113358A1 (en) | 2006-07-28 | 2008-05-15 | Ravi Kapur | Selection of cells using biomarkers |
US20080026378A1 (en) | 2006-07-28 | 2008-01-31 | Gian Franco Bottazzo | Prediction and prophylactic treatment of type 1 diabetes |
ITTO20060614A1 (it) | 2006-08-21 | 2008-02-22 | Uni Degli Studi Del Piemonte | "diagnosi differenziale per la sclerodermia" |
US20080152589A1 (en) | 2006-09-08 | 2008-06-26 | Peter Schofield | Diagnostics and Therapeutics of Neurological Disease |
JP2010503840A (ja) | 2006-09-14 | 2010-02-04 | ゾラ バイオサイエンシズ オイ | 自己免疫および1型糖尿病のリスクの早期予測ツールとしての生体流動の代謝体プロファイリング |
EP1905841A1 (en) | 2006-09-25 | 2008-04-02 | Max Delbrück Centrum für Molekulare Medizin (MDC) Berlin-Buch; | Trex1 as a marker for lupus erythematosus |
WO2008037449A2 (en) | 2006-09-26 | 2008-04-03 | Proteosys Ag | Use of at least one isoform of progesterone receptor membrane component 1 (pgrmc1) |
WO2008042012A1 (en) | 2006-10-05 | 2008-04-10 | Rhode Island Hospital | Compositions and methods for detecting and treating renal injury and inflammation |
WO2008043725A1 (en) | 2006-10-10 | 2008-04-17 | Novartis Ag | Biomarker in inflammatory disorders |
US20100029007A1 (en) | 2006-10-11 | 2010-02-04 | Novaartis Ag | Biomarker in Inflammatory Diseases |
WO2008046509A1 (en) | 2006-10-16 | 2008-04-24 | Bayer Schering Pharma Aktiengesellschaft | Ltbp2 as a biomarker, therapeutic and diagnostic target |
WO2008046510A1 (en) | 2006-10-16 | 2008-04-24 | Bayer Healthcare Ag | Fn1 as a biomarker, therapeutic and diagnostic target |
WO2008046511A1 (en) | 2006-10-16 | 2008-04-24 | Bayer Schering Pharma Aktiengesellschaft | Crtac as a biomarker, therapeutic and diagnostic target |
EP2087359A1 (en) | 2006-10-16 | 2009-08-12 | Bayer Schering Pharma AG | Prss23 as a biomarker, therapeutic and diagnostic target |
WO2008046160A1 (en) | 2006-10-20 | 2008-04-24 | Newcastle Innovation Limited | Assay for the detection of biomarkers associated with pregnancy related conditions |
CN101636175A (zh) | 2006-11-01 | 2010-01-27 | 乔治梅森知识产权公司 | 用于神经病况的生物标记 |
EP2089712A4 (en) | 2006-11-22 | 2010-09-22 | Life Technologies Corp | BIOMARKERS OF AUTOIMMUNE DISEASES |
US20100169988A1 (en) | 2006-12-06 | 2010-07-01 | Bernhard Kohli | Means and methods for isolating and determining novel targets for the treatment of neurodegenerative, neurological or neuropsychiatric disorders and compositions comprising the same |
IL180095A0 (en) | 2006-12-14 | 2007-05-15 | Ohad Birk | Method for antenatal estimation of down syndrome risk |
WO2008082519A2 (en) | 2006-12-19 | 2008-07-10 | The Trustees Of The University Of Pennsylvania | Screening for cd93 (c1qrp)-associated polymorphism(s) in the diagnosis, prevention and treatment of autoimmune diseases |
US8815519B2 (en) | 2006-12-22 | 2014-08-26 | Hvidovre Hospital | Method for predicting cancer and other diseases |
EP2155228B1 (en) | 2007-01-10 | 2014-04-02 | Purdue Research Foundation | Polypeptide inhibitors of hsp27 kinase and uses therefor |
WO2008085024A1 (en) | 2007-01-12 | 2008-07-17 | Erasmus University Medical Center Rotterdam | Identification and detection of peptides relating to specific disorders |
US8058015B2 (en) | 2007-01-22 | 2011-11-15 | Medizinische Universität Innsbruck | Markers for chronic kidney disease |
AU2008213742A1 (en) | 2007-02-08 | 2008-08-14 | Powmri Limited | Method of diagnosing a neurodegenerative disease |
WO2008100596A2 (en) | 2007-02-15 | 2008-08-21 | Burnham Institute For Medical Research | Biomarkers of neurodegenerative disease |
DK2471954T3 (en) | 2007-02-21 | 2016-09-12 | Decode Genetics Ehf | Susceptibility genetic variants associated with cardiovascular diseases |
CA2718127A1 (en) | 2007-03-14 | 2008-09-18 | Baylor Research Institute | Gene expression in peripheral blood mononuclear cells from children with diabetes |
JP2010524434A (ja) | 2007-03-26 | 2010-07-22 | ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ | Kcnh2の統合失調症関連アイソフォームおよび抗精神病薬の開発 |
EP1975252A1 (en) | 2007-03-29 | 2008-10-01 | INSERM (Institut National de la Santé et de la Recherche Medicale) | Methods for the prognosis or for the diagnosis of a thyroid disease |
US20120052592A9 (en) | 2007-03-30 | 2012-03-01 | Nano Solution, Inc., | Method for determining prognosis of acute central nervous system disorder |
PL390236A1 (pl) | 2007-04-12 | 2010-07-05 | Apitope International Nvapitope International Nv | Biomarkery stwardnienia rozsianego |
GB0707933D0 (en) | 2007-04-24 | 2007-05-30 | Apitope Technology Bristol Ltd | Disease markers |
GB0708075D0 (en) | 2007-04-26 | 2007-06-06 | Univ Nottingham | Nethods |
WO2008137586A1 (en) | 2007-05-01 | 2008-11-13 | University Of Miami | Transcriptomic biomarkers for individual risk assessment in new onset heart failure |
AU2008247395A1 (en) | 2007-05-03 | 2008-11-13 | Medimmune, Llc | Auto-antibody markers of autoimmune disease |
WO2008147938A2 (en) | 2007-05-24 | 2008-12-04 | Centocor, Inc. | Wnt5a as an inflammatory disease marker |
EP2160478B1 (en) | 2007-06-06 | 2014-08-27 | Siemens Healthcare Diagnostics Inc. | Predictive diagnostics for kidney disease |
US20090142792A1 (en) | 2007-06-21 | 2009-06-04 | Robinson William H | Biomarkers for the diagnosis of autoimmune disease |
ITRM20070351A1 (it) | 2007-06-22 | 2008-12-23 | Istituto Naz Per Le Malattie I | Gene codificante la proteina ambra 1 avente attivita' regolatoria dell autofagia e dello sviluppo del sistema nervoso centrale |
WO2009000520A1 (en) | 2007-06-25 | 2008-12-31 | Universität Duisburg-Essen | Screening-method for polymorphic markers in htra1 gene in neurodegenerative disorders |
US8227201B2 (en) | 2007-06-27 | 2012-07-24 | Board Of Trustees Of The Leland Stanford Junior University | BETA2-microglobulin and C reactive protein (CRP) as biomarkers for peripheral artery disease |
FR2918329B1 (fr) | 2007-07-06 | 2009-10-02 | Renault Sas | Ecope de refroidissement pour vehicule automobile |
EP2173438A2 (en) | 2007-07-13 | 2010-04-14 | Genentech, Inc. | Treatments and diagnostics for cancer, inflammatory disorders and autoimmune disorders |
BRPI0815095B1 (pt) | 2007-07-17 | 2021-04-13 | Metabolon, Inc | Método de classificação de um indivíduo de acordo com a tolerância à glicose predita em tolerância à glicose normal (ngt), tolerância à glicose de jejum prejudicada (ifg), ou tolerância à glicose prejudicada (igt), para diabetes tipo 2, método de determinação da suscetibilidade de um indivíduo a diabetes tipo 2 e método de monitoramento da progressão ou regressão do pré- diabetes em um indivíduo |
KR20100063052A (ko) | 2007-08-02 | 2010-06-10 | 아이에스에스 이뮨 시스템 스티뮬레이션 에이비 | 염증성 장 질환의 진단, 단계 구분 및 모니터링 방법 |
US20090275046A1 (en) | 2007-08-29 | 2009-11-05 | Power3 Medical Products, Inc. | Complement factor H protein as a biomarker of Parkinson's disease |
WO2009032722A1 (en) | 2007-08-29 | 2009-03-12 | The Cleveland Clinic Foundation | Carbamylated proteins and risk of cardiovascular disease |
US8748100B2 (en) | 2007-08-30 | 2014-06-10 | The Chinese University Of Hong Kong | Methods and kits for selectively amplifying, detecting or quantifying target DNA with specific end sequences |
GB0717637D0 (en) | 2007-09-10 | 2007-10-17 | Univ Leiden | Future cardiac event biomarkers |
US8062852B2 (en) | 2007-10-01 | 2011-11-22 | The Children's Hospital And Regional Medical Center | Detection and treatment of autoimmune disorders |
ITUD20070183A1 (it) | 2007-10-01 | 2009-04-02 | Univ Degli Studi Udine | Metodo diagnostico e prognostico per la diagnosi e la prognosi della linfoproliferazione nelle malattie autoimmuni |
GB0720113D0 (en) * | 2007-10-15 | 2007-11-28 | Cambridge Cancer Diagnostics L | Diagnostic, prognostic and predictive testing for cancer |
EP2212693B1 (en) | 2007-10-22 | 2015-04-22 | The Regents of The University of California | Biomarkers for prenatal diagnosis of congenital cytomegalovirus |
FI20070795A0 (fi) | 2007-10-24 | 2007-10-24 | Faron Pharmaceuticals Oy | Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin |
JP2011501177A (ja) | 2007-10-26 | 2011-01-06 | ビオヒット・ユルキネン・オサケユキテュア | 自己免疫疾患および萎縮性胃炎と関連する胃癌を診断するための方法および製品 |
WO2009059259A2 (en) | 2007-10-31 | 2009-05-07 | Children's Hospital Medical Center | Detection of worsening renal disease in subjects with systemic lupus erythematosus |
WO2009058168A1 (en) | 2007-11-04 | 2009-05-07 | Prediction Sciences Llc | Cellular fibronectin as a diagnostic marker in cardiovascular disease and methods of use thereof |
EP2209916B1 (en) | 2007-11-08 | 2011-12-21 | Novartis AG | Gene expression signatures for chronic/sclerosing allograft nephropathy |
US8008013B2 (en) | 2007-11-16 | 2011-08-30 | Oklahoma Medical Research Foundation | Predicting and diagnosing patients with autoimmune disease |
US20100255485A1 (en) | 2007-11-28 | 2010-10-07 | Pico Caroni | Biomarkers for the onset of neurodegenerative diseases |
US8506933B2 (en) | 2007-11-30 | 2013-08-13 | Msdx, Inc. | Methods of detecting a neurological condition via analysis of circulating phagocytes |
WO2009074331A2 (en) | 2007-12-11 | 2009-06-18 | Julius-Maximilians-Universität Würzburg | Early and differential diagnosis test for alzheimer's disease |
WO2009075566A1 (en) | 2007-12-12 | 2009-06-18 | Erasmus University Medical Center Rotterdam | Biomarkers for cardiovascular disease |
EP2075343A1 (en) | 2007-12-21 | 2009-07-01 | Gert Mayer | A method of diagnosing a progressive disease |
WO2009083950A2 (en) | 2007-12-27 | 2009-07-09 | Compugen Ltd. | Biomarkers for the prediction of renal injury |
BRPI0906858B8 (pt) * | 2008-01-18 | 2021-07-27 | Harvard College | métodos in vitro para detectar a presença de uma célula de câncer em um indivíduo e para identificar uma assinatura específica de tumor em um indivíduo tendo câncer. |
JP2011510308A (ja) | 2008-01-23 | 2011-03-31 | リグスホスピタル | バイオマーカーykl−40のレベルの測定により見出される生存予後に基く心血管疾患を患う個体の分類 |
US20090299155A1 (en) | 2008-01-30 | 2009-12-03 | Dexcom, Inc. | Continuous cardiac marker sensor system |
AU2009212463A1 (en) | 2008-02-04 | 2009-08-13 | Banyan Biomarkers, Inc. | Process to diagnose or treat brain injury |
CA2714410A1 (en) | 2008-02-08 | 2009-08-13 | Medimmune, Llc | Disease markers and uses thereof |
US20090239242A1 (en) | 2008-03-18 | 2009-09-24 | Biotrin Intellectual Properties Limited | Method for the early identification and prediction of kidney injury |
AU2008255192A1 (en) | 2008-03-22 | 2009-10-08 | Newcastle Innovation Limited | Detection of a biomarker of aberrant cells of neuroectodermal origin in a body fluid |
GB0809069D0 (en) | 2008-05-19 | 2008-06-25 | Univ Leuven Kath | Gene signatures |
WO2009122387A1 (en) | 2008-04-04 | 2009-10-08 | Biotrin Group Ltd. | Method for the detection and prediction of obesity-related renal disease |
EP2107377A1 (en) | 2008-04-04 | 2009-10-07 | BRAHMS Aktiengesellschaft | Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events |
AU2009237710A1 (en) | 2008-04-15 | 2009-10-22 | Rainer Oberbauer | Markers of acute kidney failure |
US8030097B2 (en) | 2008-04-30 | 2011-10-04 | Versitech Limited and R & C Biogenius Limited | Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks |
WO2010005750A2 (en) | 2008-06-16 | 2010-01-14 | The Regents Of The University Of California | Potential prognostic markers and therapeutic targets for neurological disorders |
US20100167937A1 (en) | 2008-07-08 | 2010-07-01 | Power3 Medical Products, Inc. | Multiple forms of Alzheimer's disease based on differences in concentrations of protein biomarkers in blood serum |
WO2010011506A2 (en) | 2008-07-23 | 2010-01-28 | The Washington University | Risk factors and a therapeutic target for neurodegenerative disorders |
WO2010012306A1 (en) | 2008-07-31 | 2010-02-04 | Queen Mary And Westfield College, University Of London | Healthy kidney biomarkers |
NO2324360T3 (es) | 2008-08-11 | 2018-06-30 | ||
ES2341419B1 (es) | 2008-08-14 | 2011-05-03 | Hospital Clinic I Provincial De Barcelona | Wnt1 como biomarcador de daño renal. |
WO2010022210A2 (en) | 2008-08-21 | 2010-02-25 | Pxbiosciences Llc | Diagnosis and monitoring of renal failure using peptide biomarkers |
EP2813848A3 (en) | 2008-08-29 | 2015-03-11 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
EP2161577A1 (en) * | 2008-09-01 | 2010-03-10 | Atlas Antibodies AB | ANLN protein |
BRPI0913687A2 (pt) | 2008-09-30 | 2015-10-13 | Genentech Inc | marcadores biológicos preditivos da resposta da artrite reumatóide aos antagonistas da linfotoxina |
US20100124756A1 (en) | 2008-10-10 | 2010-05-20 | Sandip Ray | Collection of biomarkers for diagnosis and monitoring of alzheimer's disease in body fluids |
GB0818650D0 (en) | 2008-10-10 | 2008-11-19 | Uni I Oslo | Methods |
EP2347260A4 (en) | 2008-10-21 | 2012-09-26 | Astute Medical Inc | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE |
CN102246035B (zh) | 2008-10-21 | 2014-10-22 | 阿斯图特医药公司 | 用于诊断和预后肾损伤和肾衰竭的方法和组合物 |
KR101051435B1 (ko) * | 2008-10-22 | 2011-07-22 | 한국생명공학연구원 | 대장암 관련 마커를 이용한 대장암 진단 키트 및 이를 이용한 대장암 진단 방법 |
EP2180322A1 (en) | 2008-10-22 | 2010-04-28 | BRAHMS Aktiengesellschaft | Prognostic biomarkers for the progression of primary chronic kidney disease |
EP2337864B1 (en) | 2008-10-24 | 2014-11-26 | Vereniging voor christelijk hoger onderwijs, Wetenschappelijk onderzoek en patiëntenzorg | Biomarkers for predicting the development of chronic autoimmune diseases |
WO2010048497A1 (en) | 2008-10-24 | 2010-04-29 | Genizon Biosciences Inc. | Genetic profile of the markers associated with alzheimer's disease |
EP2352502A4 (en) | 2008-11-06 | 2012-12-26 | Univ Miami | LIMITED PROTEOLYSIS OF CD2AP AND PROGRESSION OF NURSE DISEASE |
EP2364368B1 (en) | 2008-11-07 | 2014-01-15 | Sequenta, Inc. | Methods of monitoring conditions by sequence analysis |
AU2009313189B2 (en) | 2008-11-10 | 2014-10-23 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
WO2010056757A1 (en) | 2008-11-11 | 2010-05-20 | Entelos, Inc. | Biomarkers for assessing atherosclerotic potential |
WO2010059242A2 (en) | 2008-11-21 | 2010-05-27 | The Johns Hopkins University | Neurodegenerative disease diagnostic compositions and methods of use |
US20110229915A1 (en) | 2008-11-22 | 2011-09-22 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
IT1392551B1 (it) | 2008-11-25 | 2012-03-09 | Bioindustry Park Del Canavese S P A | Biomarcatori per la diagnosi e per rilevare la progressione di malattie neurodegenerative, in particolare della sclerosi laterale amiotrofica |
US20120094315A1 (en) | 2008-12-09 | 2012-04-19 | Stephanie Fryar-Williams | Biomarkers for the diagnosis and/or prediction of susceptibility to mental and neurodegenerative disorders |
US9791452B2 (en) | 2008-12-10 | 2017-10-17 | Joslin Diabetes Center, Inc. | Methods of diagnosing and predicting renal disease |
-
2011
- 2011-07-22 US US13/188,683 patent/US20120053073A1/en not_active Abandoned
- 2011-07-22 JP JP2013521843A patent/JP2013538565A/ja active Pending
- 2011-07-22 SG SG2013004791A patent/SG187159A1/en unknown
- 2011-07-22 WO PCT/US2011/044969 patent/WO2012012693A2/en active Application Filing
- 2011-07-22 SG SG10201505723UA patent/SG10201505723UA/en unknown
- 2011-07-22 EP EP20110810446 patent/EP2596132A4/en not_active Ceased
- 2011-07-22 CN CN2011800461731A patent/CN103119179A/zh active Pending
- 2011-07-22 CA CA2806291A patent/CA2806291C/en active Active
- 2011-07-22 CN CN201911204448.4A patent/CN110846405A/zh active Pending
- 2011-07-22 BR BR112013001754A patent/BR112013001754A2/pt not_active Application Discontinuation
- 2011-07-22 EP EP23188166.5A patent/EP4303584A3/en active Pending
- 2011-07-22 KR KR1020137004461A patent/KR20130041961A/ko not_active Application Discontinuation
- 2011-07-22 MX MX2013000916A patent/MX361944B/es active IP Right Grant
- 2011-07-22 EA EA201390150A patent/EA201390150A1/ru unknown
- 2011-07-22 AU AU2011280996A patent/AU2011280996B2/en active Active
-
2015
- 2015-03-20 US US14/664,176 patent/US20150299810A1/en not_active Abandoned
-
2016
- 2016-10-21 JP JP2016206825A patent/JP2017060479A/ja active Pending
-
2017
- 2017-03-02 AU AU2017201440A patent/AU2017201440B2/en active Active
-
2018
- 2018-04-17 US US15/955,199 patent/US20190085402A1/en not_active Abandoned
- 2018-11-05 JP JP2018207960A patent/JP2019068804A/ja not_active Withdrawn
-
2021
- 2021-02-05 JP JP2021017763A patent/JP2021074011A/ja active Pending
-
2022
- 2022-04-08 US US17/716,335 patent/US20220298583A1/en active Pending
- 2022-04-08 US US17/716,329 patent/US20220298582A1/en active Pending
-
2023
- 2023-05-17 JP JP2023081918A patent/JP2023101574A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
SG187159A1 (en) | 2013-02-28 |
AU2017201440B2 (en) | 2019-06-20 |
US20220298582A1 (en) | 2022-09-22 |
EP2596132A2 (en) | 2013-05-29 |
JP2021074011A (ja) | 2021-05-20 |
CA2806291C (en) | 2023-08-29 |
JP2019068804A (ja) | 2019-05-09 |
CA2806291A1 (en) | 2012-01-26 |
US20150299810A1 (en) | 2015-10-22 |
US20220298583A1 (en) | 2022-09-22 |
US20190085402A1 (en) | 2019-03-21 |
CN103119179A (zh) | 2013-05-22 |
JP2013538565A (ja) | 2013-10-17 |
EP4303584A2 (en) | 2024-01-10 |
JP2017060479A (ja) | 2017-03-30 |
AU2011280996B2 (en) | 2017-03-30 |
MX361944B (es) | 2018-12-19 |
EA201390150A1 (ru) | 2013-09-30 |
CN110846405A (zh) | 2020-02-28 |
US20120053073A1 (en) | 2012-03-01 |
AU2011280996A1 (en) | 2013-02-28 |
BR112013001754A2 (pt) | 2016-05-31 |
EP4303584A3 (en) | 2024-04-03 |
SG10201505723UA (en) | 2015-09-29 |
KR20130041961A (ko) | 2013-04-25 |
WO2012012693A2 (en) | 2012-01-26 |
AU2017201440A1 (en) | 2017-03-16 |
JP2023101574A (ja) | 2023-07-21 |
WO2012012693A3 (en) | 2012-06-14 |
EP2596132A4 (en) | 2013-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX361944B (es) | Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales. | |
BR112013001752A2 (pt) | método de detectar doenças ou condições usando células fagocídicas | |
WO2012012704A3 (en) | Methods of detecting kidney-associated diseases or conditions | |
EP4335932A3 (en) | Methods of monitoring conditions by sequence analysis | |
EA201590027A1 (ru) | Способы детекции заболеваний или состояний | |
WO2013039477A8 (en) | Non-invasive methods of detecting target molecules | |
WO2012054638A3 (en) | Nmr systems and methods for the detection of analytes | |
IL222252A (en) | A system, device and method for detecting and diagnosing biological arrhythmias | |
WO2012031008A3 (en) | Cancer-related biological materials in microvesicles | |
NZ605698A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
WO2011015602A3 (en) | Lung cancer biomarkers | |
WO2013066369A3 (en) | Methods for detecting graft-versus-host disease | |
MY175351A (en) | Method and kit for measurement of nk cell activity | |
EA201590024A1 (ru) | Способы определения заболеваний или состояний с применением циркулирующих болезненных клеток | |
MX2013000502A (es) | Metodos y kits para el diagnostico de cancer de prostata. | |
WO2014004889A3 (en) | Plasma analytes predict diagnosis and prognosis of thoracic aortic aneurysm | |
WO2010088688A3 (en) | Diagnosis of in situ and invasive breast cancer | |
EP4286847A3 (en) | Genetic abnormalities in plasma cell dyscrasias | |
AU2010202926B2 (en) | Markers and methods relating to the assessment of Alzheimer's disease | |
WO2014087255A3 (en) | Systems and methods for monitoring biological fluids | |
WO2012145399A3 (en) | Methods of diagnosing cancer in a patient | |
WO2013101276A3 (en) | Diagnosis and detection of disease conditions modulated by activation of the sphingolipid pathway | |
WO2012167887A8 (en) | Diagnostic use of prosomatostatin | |
WO2011109285A3 (en) | Prognostic marker for cryoglobulinemic vasculitis and b cell malignancies in hcv infected patients | |
GB201018312D0 (en) | Metagene expression signature for prognosis of breast cancer patients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |